AzurRx BioPharma Presents Positive Secondary Endpoint Data in its Phase II MS1819-SD Chronic Pancreatitis Study at the 2019 Digestive Disease Week Conference

Paul Theisen
Patient Acquisition

Suma Ramadas, PhD
Medical Affairs

Matthew Durham
Omnidynamic Marketing

Stacey Gandler
Brand Nourishment

Frank Burrell
Scientific Storytelling

Daniel Sontupe
Market Access

Matt Turner
Patient Affordability

Liz Kane
Impactful Strategy

Brenda Snow
Authentic Patient Voice

Joey Cohen
Medication Adherence

David Linetsky
Point-of-Care Marketing

Bud Bilanich
Success Coach

Amy Giles
Increasing Engagement

Pat Purcell
Meeting Engagement